BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -98.0% | 200 | -99.2% | 0.00% | -100.0% |
| Q1 2020 | $49,000 | +250.0% | 24,433 | +581.2% | 0.00% | +200.0% |
| Q2 2019 | $14,000 | +40.0% | 3,587 | +172.2% | 0.00% | 0.0% |
| Q3 2018 | $10,000 | +42.9% | 1,318 | +64.8% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | -90.0% | 800 | -96.8% | 0.00% | -90.0% |
| Q2 2016 | $70,000 | +311.8% | 24,700 | +311.7% | 0.01% | +400.0% |
| Q1 2016 | $17,000 | +142.9% | 6,000 | +650.0% | 0.00% | +100.0% |
| Q1 2015 | $7,000 | -87.3% | 800 | -82.2% | 0.00% | -87.5% |
| Q4 2014 | $55,000 | +71.9% | 4,500 | +36.4% | 0.01% | +60.0% |
| Q3 2014 | $32,000 | -3.0% | 3,300 | +26.9% | 0.01% | +25.0% |
| Q2 2014 | $33,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |